• Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir- Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study.
  Castagna A et al, The Journal of Infectious Diseases 2014;210:354–62
  Posted on November 18th, 2014 - Pr Pedro Cahn
• Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Refl ate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
  Grinsztejn B et al, Lancet Infect Dis 2014; 14: 459–67
  Posted on November 18th, 2014 - Dr Anton Pozniak
• Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide. An Analysis of Trial Data.
  Mollan KR et al, Ann Intern Med. 2014;161:1-10
  Posted on November 18th, 2014 - Pr François Raffi
  
• Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.
  Whitney JB et al, Nature (2014) doi:10.1038/nature13594
  18 Novembre 2014 - Pr François Raffi
  

---

Back to Home page